News
SYGGF
0.014
NaN%
--
Weekly Report: what happened at SYGGF last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at SYGGF last week (1117-1121)?
Weekly Report · 11/24 10:05
Weekly Report: what happened at SYGGF last week (1110-1114)?
Weekly Report · 11/17 10:05
Weekly Report: what happened at SYGGF last week (1103-1107)?
Weekly Report · 11/10 10:03
Weekly Report: what happened at SYGGF last week (1027-1031)?
Weekly Report · 11/03 10:04
Weekly Report: what happened at SYGGF last week (1020-1024)?
Weekly Report · 10/27 10:06
Weekly Report: what happened at SYGGF last week (1013-1017)?
Weekly Report · 10/20 10:03
Weekly Report: what happened at SYGGF last week (1006-1010)?
Weekly Report · 10/13 10:06
Weekly Report: what happened at SYGGF last week (0929-1003)?
Weekly Report · 10/06 10:03
Weekly Report: what happened at SYGGF last week (0922-0926)?
Weekly Report · 09/29 10:03
Weekly Report: what happened at SYGGF last week (0915-0919)?
Weekly Report · 09/22 10:03
Weekly Report: what happened at SYGGF last week (0908-0912)?
Weekly Report · 09/15 09:54
Weekly Report: what happened at SYGGF last week (0901-0905)?
Weekly Report · 09/08 09:55
Weekly Report: what happened at SYGGF last week (0825-0829)?
Weekly Report · 09/01 09:53
Weekly Report: what happened at SYGGF last week (0818-0822)?
Weekly Report · 08/25 09:57
Weekly Report: what happened at SYGGF last week (0811-0815)?
Weekly Report · 08/18 09:54
Weekly Report: what happened at SYGGF last week (0804-0808)?
Weekly Report · 08/11 09:57
Weekly Report: what happened at SYGGF last week (0728-0801)?
Weekly Report · 08/04 09:58
Weekly Report: what happened at SYGGF last week (0721-0725)?
Weekly Report · 07/28 09:59
Weekly Report: what happened at SYGGF last week (0714-0718)?
Weekly Report · 07/21 09:54
More
Webull provides a variety of real-time SYGGF stock news. You can receive the latest news about Synairgen Plc through multiple platforms. This information may help you make smarter investment decisions.
About SYGGF
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for the treatment and prevention of various viral lung infections in high-risk patient groups. The Company has developed and is testing an inhaled formulation of IFN-B designed to directly target the lungs, the primary site of many viral lung infections, including COVID-19.